BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
72.01
+0.29 (0.40%)
At close: Nov 28, 2025, 1:00 PM EST
72.49
+0.48 (0.67%)
After-hours: Nov 28, 2025, 4:51 PM EST
BridgeBio Pharma Employees
As of December 31, 2024, BridgeBio Pharma had 730 total employees, including 725 full-time and 5 part-time employees. The number of employees increased by 174 or 31.29% compared to the previous year.
Employees
730
Change (1Y)
174
Growth (1Y)
31.29%
Revenue / Employee
$484,630
Profits / Employee
-$1,091,942
Market Cap
13.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 730 | 174 | 31.29% |
| Dec 31, 2023 | 556 | 160 | 40.40% |
| Dec 31, 2022 | 396 | -182 | -31.49% |
| Dec 31, 2021 | 578 | 182 | 45.96% |
| Dec 31, 2020 | 396 | 148 | 59.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BBIO News
- 4 days ago - BridgeBio to Participate in December Investor Conferences - GlobeNewsWire
- 6 days ago - BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha
- 9 days ago - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - BridgeBio Pharma, Inc. (BBIO) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 21 days ago - Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations - GlobeNewsWire
- 22 days ago - National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry - GlobeNewsWire
- 25 days ago - BridgeBio to Participate in November Investor Conferences - GlobeNewsWire
- 26 days ago - Biotech is back. Here's why these rallying stocks belong in your portfolio now. - Market Watch